AIPCTShop: Pharmaceuticals, Medication & Supplements Guide
  • About AIPCTShop
  • AIPCTShop Terms of Service Agreement
  • Privacy Policy
  • GDPR Compliance Guide
  • Get in Touch
AIPCTShop: Pharmaceuticals, Medication & Supplements Guide
  • About AIPCTShop
  • AIPCTShop Terms of Service Agreement
  • Privacy Policy
  • GDPR Compliance Guide
  • Get in Touch

Archive: 2024 / 03

GlaxoSmithKline Withdraws Inhaler Patents Amid FTC Crackdown on Non-Inventive Listings
22.03.2024

GlaxoSmithKline Withdraws Inhaler Patents Amid FTC Crackdown on Non-Inventive Listings

In an unprecedented move, GlaxoSmithKline has retracted patent listings for Advair, Flovent, and Ventolin from the FDA’s Orange Book. This decision came after the FTC's scrutiny over non-inventive patent listings intensified, affecting several pharmaceutical companies aiming to maintain market exclusivity.
Arlen Fairweather
by Arlen Fairweather
  • Healthcare Policy
  • 0

Categories

  • Health and Wellness (16)
  • Health & Wellness (8)
  • Legal (3)
  • Health and Fitness (2)
  • Health and Medicine (2)
  • Health (2)
  • Skincare (2)
  • Health and Medical Research (1)
  • Oncology News and Research (1)
  • Oncology and Hematology (1)

Latest posts

DVT and Sleep: The Importance of Proper Rest
Discover the Amazing Health Benefits of Thuja Dietary Supplements!
Coping with the Emotional Challenges of Ankylosing Spondylitis
Transform Your Wellness Journey with the Amazing Poisonous Buttercup Supplement
Exploring 10 Alternatives to Paroxetine for Depression

Archives

  • June 2025 (3)
  • May 2025 (3)
  • April 2025 (4)
  • March 2025 (4)
  • February 2025 (3)
  • January 2025 (4)
  • December 2024 (2)
  • October 2024 (2)
  • September 2024 (1)
  • August 2024 (1)
  • July 2024 (1)
  • May 2024 (1)
AIPCTShop: Pharmaceuticals, Medication & Supplements Guide
© 2025. All rights reserved.